More News
Want to Read Locked Articles?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
2023 in Review: Bausch + Lomb Makes Big Moves, Adding Product Lines and Building Partnerships
Author: Kristen Harmon Ingenito, MBA
Bausch + Lomb made a flurry of big moves in 2023, with product approvals, acquisitions, leadership changes, and strategic partnerships and collaborations following the company’s IPO in mid-2022. In February, the firm announced that Brent Saunders was returning to lead the company. Saunders had previously served as chief executive officer of B+L from 2010 to 2013. Saunders is well known for his deal-making, beginning in 2013 when he orchestrated Valeant Pharmaceuticals’ $8.7 billion buyout of ...
Purchasing one of the following products will open up access to this article's content, which is also available in each comprehensive report/subscription.
This website uses cookies to ensure you get the best experience. By continuing to use our website, you consent to our use of cookies.